stocktools
Dilution profile // every instrument, one screen, from SEC filings

Addex Therapeutics Ltd. (ADXN)

CIK 1574232 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$150M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
MEDIUM+92% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
NOT COMPUTEDrunway not computable from latest facts
= cash vs trailing operating burn

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2019-12-312025-12-31

Latest: 147.8M shares as of Dec 31, 2025 (20-F).

Cash runway

Not enough filing data

can’t compute a runway

Full breakdown: cash runway tool

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Registrations and offerings

Registered offering capacity on live registrations: $150.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-3Nov 19, 2025$150.0M registeredfiling →

Last 12 months: 1 executed · 1 registered.

EXECUTEDDec 10, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EFFECTIVEDec 5, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDNov 19, 2025F-3 registration — capacity to sell shares, not a sale yetF-3 →
UPDATEApr 24, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEApr 22, 2024SEC declared a registration effective — selling can beginEFFECT →
EXECUTEDJan 30, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
UPDATENov 30, 2023Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVENov 29, 2023SEC declared a registration effective — selling can beginEFFECT →
UPDATEOct 23, 2023Prospectus update — often a resale registration, not necessarily new capital424B3 →
UPDATEAug 11, 2023Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEAug 10, 2023SEC declared a registration effective — selling can beginEFFECT →
UPDATEJun 2, 2023Prospectus update — often a resale registration, not necessarily new capital424B3 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full ADXN workspace